Abbvie Limited

Lobbying Organisation Abbvie Limited

Date published 21 Sep, 2018

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 May, 2018 to 31 Aug, 2018

Specific Details Provided Industry briefing on delay in access to new medicines in Ireland

Intended results A national policy on access to medicines that improves Irelands ranking in Europe on availablity of new innovative medicines for Irish patients

Name of person primarily responsible for lobbying on this activity Paula Guerin

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Email (1)

Emailed the Minister a copy of the Irish Pharmaceutical Healthcare Association (IPHA) briefing document for policymakers entitled ' New Medicines for Patients as fast as in Europe'

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Jim Daly Minister of State (Department of Health)